Caidya announces a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle.
Read the full article: Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution //
Source: https://www.businesswire.com/news/home/20260630863968/en/Caidya-Announces-Strategic-Combination-with-Simbec-Orion-Bridging-Early-Scientific-Insight-and-Global-Clinical-Execution